Chan Cheah, Mohamed Shanavas, Julio Chavez, Yanhong Tong, Xiaoyun (Nicole) Li, Prasanna Kumar, Amit Agarwal, Mary Ann Anderson, Nitin Jain. "CaDAnCe-104, an ongoing, open-label, phase 1b/2 master protocol study of Bruton tyrosine kinase degrader BGB-16673 in combination with other agents in patients with relapsed/refractory B-cell malignancies." Blood (2025). https://doi.org/10.1182/blood-2025-1839